ATE270545T1 - Verwendung von nmda antagonisten zur behandlung des reizkolons - Google Patents

Verwendung von nmda antagonisten zur behandlung des reizkolons

Info

Publication number: ATE270545T1
Authority: AT; Austria
Prior art keywords: nmda antagonists; irritable colon; treat irritable; treat; colon
Prior art date: 1998-04-28

Application number

AT99947024T

Other languages

English (en)

Inventor

Aziz Asghar

Jose Luis Cabero

Andrew Astrazeneca Dray

Anne King

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-28

Filing date

1999-04-28

Publication date

2004-07-15

1998-04-28 Priority claimed from SE9801494A external-priority patent/SE9801494D0/xx

1998-11-18 Priority claimed from SE9803954A external-priority patent/SE9803954D0/xx

1999-04-28 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2004-07-15 Application granted granted Critical

2004-07-15 Publication of ATE270545T1 publication Critical patent/ATE270545T1/de

Links

HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
208000002551 irritable bowel syndrome Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT99947024T 1998-04-28 1999-04-28 Verwendung von nmda antagonisten zur behandlung des reizkolons ATE270545T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9801494A SE9801494D0 (sv)	1998-04-28	1998-04-28	Novel use
SE9803954A SE9803954D0 (sv)	1998-11-18	1998-11-18	Novel use
PCT/SE1999/000702 WO1999055323A1 (en)	1998-04-28	1999-04-28	Use of nmda antagonists for treatment of irritable bowel syndrome

Publications (1)

Publication Number	Publication Date
ATE270545T1 true ATE270545T1 (de)	2004-07-15

Family

ID=26663287

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99947024T ATE270545T1 (de)	1998-04-28	1999-04-28	Verwendung von nmda antagonisten zur behandlung des reizkolons

Country Status (20)

Country	Link
EP (1)	EP1073431B1 (de)
JP (1)	JP2002512956A (de)
KR (1)	KR100569777B1 (de)
CN (1)	CN1200702C (de)
AR (1)	AR016212A1 (de)
AT (1)	ATE270545T1 (de)
AU (1)	AU760783B2 (de)
BR (1)	BR9909971A (de)
CA (1)	CA2329328A1 (de)
DE (1)	DE69918541T2 (de)
DK (1)	DK1073431T3 (de)
ES (1)	ES2221753T3 (de)
IL (1)	IL138919A0 (de)
MY (1)	MY121063A (de)
NO (1)	NO20005386D0 (de)
NZ (1)	NZ507436A (de)
PT (1)	PT1073431E (de)
SA (1)	SA99200482B1 (de)
TW (1)	TW570793B (de)
WO (1)	WO1999055323A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3582101A (en) *	2000-03-01	2001-09-12	Euro-Celtique S.A.	The treatment of functional gastrointestinal disorders
TW593223B (en) *	2000-06-20	2004-06-21	Merz Pharma Gmbh & Co Kgaa	1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
JP2003081872A (ja) *	2001-09-13	2003-03-19	Nippon Oruganon Kk	掻痒治療薬
ES2294480T3 (es) *	2003-03-14	2008-04-01	Agi Therapeutics Research Limited	Tratamiento de afecciones instestinales con n-2,3,3-tetrametilbiciclo(2.1.1)heptan-2-amina.
WO2004084889A1 (en) *	2003-03-28	2004-10-07	Pfizer Inc.	Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
FR2865133B1 (fr) *	2004-01-19	2008-01-18	Rytek	Compositions pour le traitement de pathologies digestives
WO2020006629A1 (en) *	2018-07-06	2020-01-09	Algernon Pharmaceuticals Inc.	Compounds for treatment of inflammatory bowel disease and methods thereof
KR102211282B1 (ko)	2019-11-20	2021-02-03	(주)파이브텍	데이터 라우팅 방법 및 이를 지원하는 스위치

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL84305A (en) *	1987-02-06	1992-01-15	Fisons Corp	2-aminoacetamide derivatives
GB9518027D0 (en) *	1995-09-05	1995-11-08	Wellcome Found	Pharmacologically active compound
AUPN605795A0 (en) *	1995-10-19	1995-11-09	F.H. Faulding & Co. Limited	Analgesic pharmaceutical composition

1999
- 1999-04-20 AR ARP990101817A patent/AR016212A1/es unknown
- 1999-04-27 MY MYPI99001635A patent/MY121063A/en unknown
- 1999-04-28 KR KR1020007011958A patent/KR100569777B1/ko not_active Expired - Fee Related
- 1999-04-28 AT AT99947024T patent/ATE270545T1/de not_active IP Right Cessation
- 1999-04-28 IL IL13891999A patent/IL138919A0/xx not_active IP Right Cessation
- 1999-04-28 DK DK99947024T patent/DK1073431T3/da active
- 1999-04-28 ES ES99947024T patent/ES2221753T3/es not_active Expired - Lifetime
- 1999-04-28 PT PT99947024T patent/PT1073431E/pt unknown
- 1999-04-28 AU AU43024/99A patent/AU760783B2/en not_active Ceased
- 1999-04-28 CA CA002329328A patent/CA2329328A1/en not_active Abandoned
- 1999-04-28 DE DE69918541T patent/DE69918541T2/de not_active Expired - Fee Related
- 1999-04-28 CN CNB998078182A patent/CN1200702C/zh not_active Expired - Fee Related
- 1999-04-28 BR BR9909971-3A patent/BR9909971A/pt not_active Application Discontinuation
- 1999-04-28 NZ NZ507436A patent/NZ507436A/en unknown
- 1999-04-28 JP JP2000545522A patent/JP2002512956A/ja active Pending
- 1999-04-28 WO PCT/SE1999/000702 patent/WO1999055323A1/en not_active Ceased
- 1999-04-28 EP EP99947024A patent/EP1073431B1/de not_active Expired - Lifetime
- 1999-08-13 TW TW088113888A patent/TW570793B/zh active
- 1999-08-17 SA SA99200482A patent/SA99200482B1/ar unknown
2000
- 2000-10-26 NO NO20005386A patent/NO20005386D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR9909971A (pt)	2000-12-26
MY121063A (en)	2005-12-30
CN1307471A (zh)	2001-08-08
DK1073431T3 (da)	2004-10-04
EP1073431B1 (de)	2004-07-07
NO20005386L (no)	2000-10-26
DE69918541T2 (de)	2005-08-18
DE69918541D1 (de)	2004-08-12
TW570793B (en)	2004-01-11
ES2221753T3 (es)	2005-01-01
WO1999055323A1 (en)	1999-11-04
JP2002512956A (ja)	2002-05-08
KR100569777B1 (ko)	2006-04-11
PT1073431E (pt)	2004-10-29
AR016212A1 (es)	2001-06-20
SA99200482B1 (ar)	2006-06-27
HK1033876A1 (en)	2001-09-28
EP1073431A1 (de)	2001-02-07
NO20005386D0 (no)	2000-10-26
IL138919A0 (en)	2001-11-25
NZ507436A (en)	2003-09-26
AU760783B2 (en)	2003-05-22
AU4302499A (en)	1999-11-16
KR20010043077A (ko)	2001-05-25
CA2329328A1 (en)	1999-11-04
CN1200702C (zh)	2005-05-11

Legal Events

Date

Code

Title

Description

2005-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1073431

Country of ref document: EP

2008-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE365042T1 (de)	2007-07-15	Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE69722681D1 (de)	2003-07-10	Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
ATE288748T1 (de)	2005-02-15	Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE401909T1 (de)	2008-08-15	Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis
DE69925306D1 (de)	2005-06-16	Behandlung von kohlenwasserstoffgas
DE69836915D1 (de)	2007-03-08	Mundpflegemittel zur behandlung von übelriechendem atem
ATE308364T1 (de)	2005-11-15	Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE247987T1 (de)	2003-09-15	Behandlung zur beseitigung von gerüchen
ATE300597T1 (de)	2005-08-15	Behandlung von geweben
ATE260332T1 (de)	2004-03-15	Behandlung von textilien
DE69827126D1 (de)	2004-11-25	Verwendung von hypothalamus-hemmfaktor zur behandlung von ischämischen herzstörungen
ATE353218T1 (de)	2007-02-15	Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
DE69625877D1 (de)	2003-02-27	Verwendung von 5-HT1A Rezeptor-Liganden zur Behandlung des Glaukoms
DE60021903D1 (de)	2005-09-15	Verwendung von zusammensetzungen zur textilpflege
DE60130661D1 (de)	2007-11-08	Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE210447T1 (de)	2001-12-15	Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
ATE339955T1 (de)	2006-10-15	Verwendung von escitalopram zur behandlung von generalisierten angstzuständen
ATE270545T1 (de)	2004-07-15	Verwendung von nmda antagonisten zur behandlung des reizkolons
ATE410181T1 (de)	2008-10-15	Verwendung von intereferon gamma zur behandlung von herzhypertrophie
DE69621447D1 (de)	2002-07-04	Verwendung von nitroflavonoide zur behandlung von angstzuständen
ATE326969T1 (de)	2006-06-15	Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
ATE261304T1 (de)	2004-03-15	Verwendung von eletriptan zur vorbeugung des wiederauftretens der migräne
ATE270102T1 (de)	2004-07-15	Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE60103503D1 (de)	2004-07-01	Verwendung von fsh zur behandlung von infertilität
DE60117122D1 (de)	2006-04-20	Verwendung von mirtazapin zur behandlung von schlafstörungen